[go: up one dir, main page]

AR109846A1 - Validación de aclaramiento viral continuo - Google Patents

Validación de aclaramiento viral continuo

Info

Publication number
AR109846A1
AR109846A1 ARP170102921A ARP170102921A AR109846A1 AR 109846 A1 AR109846 A1 AR 109846A1 AR P170102921 A ARP170102921 A AR P170102921A AR P170102921 A ARP170102921 A AR P170102921A AR 109846 A1 AR109846 A1 AR 109846A1
Authority
AR
Argentina
Prior art keywords
validation
viral clearance
probe
continuous viral
continuous
Prior art date
Application number
ARP170102921A
Other languages
English (en)
Inventor
Lobedann Martin Dr
Laura Holtmann
Schwan Peter Dr
Maiser Benjamin Dr
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of AR109846A1 publication Critical patent/AR109846A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22—Testing for sterility conditions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2103/05—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)

Abstract

Se describe un método para la validación del aclaramiento viral continuo que comprende las etapas de a) proporcionar una sonda para su validación, b) adición de virus a la sonda en forma válida, c) realizar el aclaramiento viral, d) muestreo de la sonda a la que se han agregado virus y e) analizar la muestra de la sonda con agregado de virus de la etapa d).
ARP170102921A 2016-10-21 2017-10-20 Validación de aclaramiento viral continuo AR109846A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16194959.9A EP3141611A3 (en) 2016-10-21 2016-10-21 Validation of continuous viral clearance

Publications (1)

Publication Number Publication Date
AR109846A1 true AR109846A1 (es) 2019-01-30

Family

ID=57209212

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170102921A AR109846A1 (es) 2016-10-21 2017-10-20 Validación de aclaramiento viral continuo

Country Status (16)

Country Link
US (1) US10894991B2 (es)
EP (2) EP3141611A3 (es)
JP (1) JP2019537435A (es)
KR (1) KR20190066017A (es)
CN (1) CN110100008A (es)
AR (1) AR109846A1 (es)
AU (1) AU2017345412A1 (es)
BR (1) BR112019007835A2 (es)
CA (1) CA3041253A1 (es)
IL (1) IL266095A (es)
MX (1) MX385466B (es)
RU (1) RU2755634C2 (es)
SG (1) SG10202104023QA (es)
TW (1) TW201827830A (es)
UY (1) UY37447A (es)
WO (1) WO2018075716A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111050809B (zh) * 2017-07-10 2021-12-24 武田药品工业株式会社 孵育液体和灭活病毒的方法
EP4112735A4 (en) * 2020-02-28 2023-09-06 Asahi Kasei Medical Co., Ltd. Method for evaluating viral clearance performance
US20230335297A1 (en) * 2020-09-21 2023-10-19 Bayer Healthcare Llc Pathogen Clearance System and Method
US12203914B2 (en) * 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
JP7612001B2 (ja) * 2021-03-26 2025-01-10 旭化成メディカル株式会社 ウイルスクリアランス試験の方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013523175A (ja) * 2010-04-14 2013-06-17 イーエムディー・ミリポア・コーポレーション 高力価、高純度のウイルスストックの作製方法及びその使用方法
AU2014100888A4 (en) * 2014-08-07 2014-09-11 Novartis Ag Virus clearance and protein purification methods

Also Published As

Publication number Publication date
US20190316213A1 (en) 2019-10-17
MX385466B (es) 2025-03-18
MX2019004540A (es) 2019-06-12
RU2019115375A3 (es) 2021-03-19
AU2017345412A1 (en) 2019-04-18
US10894991B2 (en) 2021-01-19
EP3529367A1 (en) 2019-08-28
EP3141611A3 (en) 2017-05-10
WO2018075716A1 (en) 2018-04-26
JP2019537435A (ja) 2019-12-26
UY37447A (es) 2018-05-31
BR112019007835A2 (pt) 2019-10-01
IL266095A (en) 2019-06-30
EP3141611A2 (en) 2017-03-15
CA3041253A1 (en) 2018-04-26
RU2019115375A (ru) 2020-11-23
TW201827830A (zh) 2018-08-01
KR20190066017A (ko) 2019-06-12
SG10202104023QA (en) 2021-06-29
RU2755634C2 (ru) 2021-09-17
CN110100008A (zh) 2019-08-06

Similar Documents

Publication Publication Date Title
AR109846A1 (es) Validación de aclaramiento viral continuo
CL2019000278A1 (es) Agentes rnai para infección con virus de hepatitis b.
IL280559A (en) Hepatitis b virus (hbv) dsrna agent compositions and methods of use thereof
IL256644B (en) System and method for management, execution, and analysis of laboratory experiments
CO2017003490A2 (es) Moléculas de anticuerpos a pd-l1
DK3643795T3 (da) Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering
CL2015003608A1 (es) Evento transgénico de soja mon87751 y métodos para su detección y uso.
IL248104B (en) Defect sampling for electron beam review based on defect attributes from optical inspection and optical review
DK3224755T3 (da) Statistisk analysefremgangsmåde til bestemmelse af risiko ved filbaseret indhold
IL249503A0 (en) Scanning electron microscope and methods of inspecting and reviewing samples
MA52506A (fr) Procédés de traitement d'infections par des virus nipah
DK3325664T3 (da) Analyse af fragmenteringsmønstre for cellefrit DNA
DK3194612T3 (da) Fremgangsmåder til kvantitativ genetisk analyse af cellefrit dna
IL271147A (en) Methods for accurate computational decomposition of dna mixtures from contributors of unknown genotypes
IL253710B (en) Biomarkers for pancreatic cancer and kits and methods for detecting same
EP3414650A4 (en) SOCIAL KEYBOARD
PE20180171A1 (es) Neutralizacion del virus chikungunya mediada por anticuerpos
MX2016013877A (es) Composiciones y metodos para mejorar y/o predecir la amplificacion de adn.
NI201600147A (es) Métodos y aparato para la coordinación de la selección del sistema entre un conjunto de nodos
MX2017003635A (es) Metodo para medir la reactividad del factor de coagulacion viii (fviii).
EA201990730A1 (ru) Рнк-биомаркеры для наследственного ангионевротического отека
BR112018008757A2 (pt) suspensor de liner
EP3625349A4 (en) MODIFIED VIRUSES
DK3555313T3 (da) Molekylær detektering ved hjælp af ligeringsamplifikation
CR20160513A (es) Deteccion de fenotipo de cobertor en palma

Legal Events

Date Code Title Description
FA Abandonment or withdrawal